Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Notice of alternative medication authorization, May 31, 2023

Legal publication
Updated on

 08 June 2023

This notice was published on June 8, 2023.

  • Prazosin hydrochloride, capsules, 0.5 mg replaces Teva-Prazosin, tablets, 1 mg
  • Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
  • Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
  • Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Download (.pdf)
 101.72 KB
Related topics